Emiel De Jaeghere

PhD Thesis
open access

Immune checkpoint inhibitors in gynecologic cancer : getting to prime T(I)ME?

Emiel De Jaeghere (UGent)

(2025)

Miscellaneous
open access

Pembrolizumab, radiotherapy, and an immunomodulatory five-drug cocktail in pretreated patients with persistent, recurrent, or metastatic cervical or endometrial carcinoma : results of the phase II PRIMMO study (vol 72, pg 475, 2022)

Emiel De Jaeghere (UGent) , Sandra Tuyaerts, An M. T. Van Nufel, Ann Belmans, Kris Bogaerts, Regina Baiden-Amissah, Lien Lippens (UGent) , Peter Vuylsteke, Stéphanie Henry, Xuan Bich Trinh, et al.

(2024) CANCER IMMUNOLOGY IMMUNOTHERAPY. 74(1).

Add to list

Journal Article
A1
open access

Associations of the gut microbiome with outcomes in cervical and endometrial cancer patients treated with pembrolizumab : insights from the phase II PRIMMO trial

Emiel De Jaeghere (UGent) , Hannelore Hamerlinck (UGent) , Sandra Tuyaerts, Lien Lippens (UGent) , An M.T. Van Nuffel, Regina Baiden-Amissah, Peter Vuylsteke, Stéphanie Henry, Xuan Bich Trinh, Peter A. van Dam, et al.

(2024) GYNECOLOGIC ONCOLOGY. 191. p.275-286

Add to list

Journal Article
A1
open access

Identification of potentially actionable genetic variants in epithelial ovarian cancer : a retrospective cohort study

Charlotte Fieuws (UGent) , Joni Van der Meulen (UGent) , Kristiaan Proesmans (UGent) , Emiel De Jaeghere (UGent) , Siebe Loontiens (UGent) , Jo Van Dorpe (UGent) , Philippe Tummers (UGent) , Hannelore Denys (UGent) , Koen Van de Vijver (UGent) and Kathleen Claes (UGent)

(2024) NPJ PRECISION ONCOLOGY. 8(1).

Add to list

Sexual health in Belgian cervical cancer survivors : an exploratory qualitative study

Eline Naert (UGent) , Hans Van Hulle, Emiel De Jaeghere (UGent) , Marjolein Orije (UGent) , Sarah Roels, Rawand Salihi (UGent) , Koen J. Traen, Kristien Watty, Lise-Marie Kinnaer (UGent) , Hans Verstraelen (UGent) , et al.

(2024) QUALITY OF LIFE RESEARCH. 33(5). p.1401-1414

Add to list

A breath of relief : navigating the resolution of unexplained respiratory failure

Thor Hautekiet, Emiel De Jaeghere (UGent) , Nina Cardinaels (UGent) , Yannick Vande Weygaerde (UGent) , Dieter Stevens (UGent) , Eric Derom (UGent) and Pieter Depuydt (UGent)

(2023) Belgian Pneumology Days 2023, Abstracts. In Belgian Pneumology Days

Add to list

Vaginal morbidity, sexual functioning, and health-related quality of life in cervical cancer survivors : a cross-sectional multicenter study (VAMOS)

Eline Naert (UGent) , Alexander Decruyenaere (UGent) , Renée Bultijnck (UGent) , Emiel De Jaeghere (UGent) , Marjolein Orije (UGent) , Rawand Salihi (UGent) , Hans Verstraelen (UGent) , Philippe Tummers (UGent) , Hannelore Denys (UGent) and Katrien Vandecasteele (UGent)

(2023) SUPPORTIVE CARE IN CANCER. 31(12).

Add to list

Performance of MRI for detection of >=T1b disease in local staging of endometrial cancer

Leonie Van Vynckt, Philippe Tummers (UGent) , Emiel De Jaeghere (UGent) , Hannelore Denys (UGent) , Menekse GOKER (UGent) , Hendrickx Sigi, Eline Naert (UGent) , Rawand Salihi (UGent) , Koen Van de Vijver (UGent) , Gabriëlle van Ramshorst (UGent) , et al.

(2023) 29th European Symposium on Urogenital Radiology (ESUR 2023), Abstracts.

Add to list

Journal Article
A1
open access

Completion surgery after intensity-modulated arc therapy for locally advanced cervical cancer : long-term follow-up and update on surgical outcome and oncologic results of a unique tertiary care single-center retrospective cohort

Axel Van Damme, Julie Rombaut, Amin Makar (UGent) , Emiel De Jaeghere (UGent) , Eline Naert (UGent) , Hannelore Denys (UGent) , Rawand Salihi (UGent) , Philippe Tummers (UGent) and Katrien Vandecasteele (UGent)

(2023) WORLD JOURNAL OF SURGICAL ONCOLOGY. 21(1).

Add to list

Journal Article
A1
open access

Pembrolizumab, radiotherapy, and an immunomodulatory five-drug cocktail in pretreated patients with persistent, recurrent, or metastatic cervical or endometrial carcinoma : results of the phase II PRIMMO study

Emiel De Jaeghere (UGent) , Sandra Tuyaerts, An M. T. Van Nuffel, Ann Belmans, Kris Bogaerts, Regina Baiden-Amissah, Lien Lippens (UGent) , Peter Vuylsteke, Stéphanie Henry, Xuan Bich Trinh, et al.

(2023) CANCER IMMUNOLOGY IMMUNOTHERAPY. 72(2). p.475-491

Academic Bibliography

Emiel De Jaeghere

Immune checkpoint inhibitors in gynecologic cancer : getting to prime T(I)ME?

Pembrolizumab, radiotherapy, and an immunomodulatory five-drug cocktail in pretreated patients with persistent, recurrent, or metastatic cervical or endometrial carcinoma : results of the phase II PRIMMO study (vol 72, pg 475, 2022)

Associations of the gut microbiome with outcomes in cervical and endometrial cancer patients treated with pembrolizumab : insights from the phase II PRIMMO trial

Identification of potentially actionable genetic variants in epithelial ovarian cancer : a retrospective cohort study

Sexual health in Belgian cervical cancer survivors : an exploratory qualitative study

A breath of relief : navigating the resolution of unexplained respiratory failure

Vaginal morbidity, sexual functioning, and health-related quality of life in cervical cancer survivors : a cross-sectional multicenter study (VAMOS)

Performance of MRI for detection of >=T1b disease in local staging of endometrial cancer

Completion surgery after intensity-modulated arc therapy for locally advanced cervical cancer : long-term follow-up and update on surgical outcome and oncologic results of a unique tertiary care single-center retrospective cohort

Pembrolizumab, radiotherapy, and an immunomodulatory five-drug cocktail in pretreated patients with persistent, recurrent, or metastatic cervical or endometrial carcinoma : results of the phase II PRIMMO study

Contents

Support

Contact